- Home
- PDS vs CBLL Comparison
PDS vs CBLL Comparison
Compare PDS & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | PDS | CBLL |
|---|---|---|
| Founded | 1951 | 2014 |
| Country | Canada | United States |
| Employees | N/A | 280 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 918.1M | 750.1M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | PDS | CBLL |
|---|---|---|
| Price | $94.53 | $16.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $122.33 | $23.20 |
| AVG Volume (30 Days) | 97.9K | ★ 285.3K |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.66 | $29.57 |
| Revenue Next Year | $2.31 | $28.44 |
| P/E Ratio | $884.15 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $41.95 | $10.85 |
| 52 Week High | $103.80 | $24.33 |
Technical Indicators
Market Signals| Indicator | PDS | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 53.30 | 31.17 |
| Support Level | $83.72 | $11.17 |
| Resistance Level | $103.13 | $20.25 |
| Average True Range (ATR) | 2.91 | 1.10 |
| MACD | 0.07 | -0.52 |
| Stochastic Oscillator | 46.28 | 9.80 |
Price Performance
Historical ComparisonAbout PDS Precision Drilling Corporation
Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.
About CBLL CeriBell Inc.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.